BD Oncology
Enhancing Oncology Care: The Market Pilot Agency’s Marketing Success Story
The world of oncology care is a complex and evolving landscape, presenting challenges that demand innovative solutions. Each year, Europe sees over 3.7 million new cancer patients, placing increasing pressure on healthcare systems. This is further compounded by the rising cost of cancer treatment, which now totals €199 billion and continues to grow due to increasing patient volumes and the high cost of new therapies.
This environment places significant demands on healthcare providers to optimise drug usage and reduce waste. Amid these challenges, BD Oncology, a division of the global medical technology leader BD, identified an opportunity to transform the entire oncology pathway.
With a strong commitment to enhancing healthcare delivery worldwide and an annual turnover of $17.5 billion, BD Oncology set out on an ambitious mission: to develop the first and only end-to-end solution designed to revolutionise oncology services — from prescription to preparation and administration. Their vision was bold, but they understood that communicating the value of such a groundbreaking solution required a strategic and comprehensive marketing approach.